Preparation and phase II clinical examination of topical dosage forms for the treatment of carcinoma colli containing bleomycin, carboquone, or 5-fluorouracil with hydroxypropyl cellulose.
D000180:Acrylic Resins / Q000008:administration & dosage; D000287:Administration, Topical; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001389:Azirines / Q000008:administration & dosage*; D001761:Bleomycin / Q000008:administration & dosage* / Q000627:therapeutic use; D002225:Carbazilquinone / Q000008:administration & dosage* / Q000627:therapeutic use; D002482:Cellulose / Q000008:administration & dosage / Q000031:analogs & derivatives; D002584:Cervix Uteri; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D011145:Polyvinyls / Q000008:administration & dosage; D013488:Suppositories; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*
D000180:Acrylic Resins; D000970:Antineoplastic Agents; D001389:Azirines; D011145:Polyvinyls; D013488:Suppositories; D001761:Bleomycin; D002225:Carbazilquinone; C006903:carbopol 940; D002482:Cellulose; C008079:hydroxypropylcellulose; D005472:Fluorouracil